MedTrace Logo

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis

NCT02606760 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 378

Last updated 2018-03-08

No results posted yet for this study

Summary

The purpose of this study is to confirm the clinical efficacy and the safety of P-3073 in patients affected by isolated psoriatic nail(s) and/or those with psoriatic nails and concomitant mild to moderate plaque psoriasis.

Conditions

  • Nail Psoriasis

Interventions

DRUG

P-3073

DRUG

Vehicle of P-3073

Sponsors & Collaborators

  • Polichem S.A.

    lead INDUSTRY

Principal Investigators

  • Maurizio Caserini, MD · Polichem S.A.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-23
Primary Completion
2017-02-08
Completion
2017-02-08

Countries

  • Bulgaria
  • Czechia
  • Germany
  • Greece
  • Latvia
  • Poland
  • Russia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02606760 on ClinicalTrials.gov